Ray R. Rogers
Ray remains the chairman of the board of RRR International Investments, a firm specializing in financing, corporate restructuring, and mergers and acquisitions. He founded International Bioclinical in 1983, and in 1994 merged the profitable diagnostic business with Bioxytech and DDI Pharmaceuticals, Inc. to form OXIS International. In addition, Rogers has been involved in several start-up and mid-level companies as both an investor and operator. He also has served on several for-profit and non-profit boards.
James F. Heinle
Prior to joining the API team, Jim’s 30+ year career spanned a variety of global roles and responsibilities with leading animal health companies. His managerial experiences include business unit P&L ownership, field sales, key account, marketing, technical service, R&D, pharmacovigilence and business development leadership positions. His various roles covered all major specie segments within the animal health industry- companion and food animal. Equally, Jim has broad brand management experience in all primary product catagories from anti-infectives, biologics, parasiticides, growth promotants, antimicrobials and antibacterials.
Heidi has been part of the API team for nearly nine years. Prior to joining API, Anderson worked in the biotech industry as a QC manager for nearly a decade.